We are proud to be part of the Chemical Biology Consortium (CBC) in the NCI Experimental Therapeutics (NExT) Program, which brings together chemical biologists and molecular oncologists from government, industry, and academia to create new cancer medicines in epigenetic, kinase, and other areas.
As a Specialized Center, we provide uniquely focused technologies that facilitate the successful progression of NExT discovery projects at specific discovery stages.